President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result in shortages and higher prices for generic drugs. By Rebecca Robbins ...

The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission remains on guard, considering further tariff deployments likely.

Roni Kamhi, CEO BI Sky Global and COO of Innocan Pharma commented: "We are very pleased with our outstanding results and especially our strong revenue growth. At BI Sky Global we are clearly ...

MUMBAI, India and WALTHAM, Mass., March 9, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE ...

Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of $355 million, or $4.10 per share, the companies said Sunday. With Unloxcyt, an FDA-approved PD-L1 therapy for ...

Governments and employers worldwide have expanded access to care. Yet pharmaceutical innovation hasn’t kept pace. Since the blockbuster success of drugs such as Prozac and Zoloft in the 1990s ...

It demands significant resources that are often expensive and inaccessible to biotechnology and pharmaceutical companies of all sizes. Federal regulations like the Current Good Manufacturing ...

Try Now>> See the top stocks recommended by analysts >> Read More on URGN: UroGen Pharma NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme ...

“Ireland has our pharma companies,” said US president Donald Trump on Wednesday in some of the most significant comments of his encounter with Taoiseach Micheál Martin. And he wants them bac ...

March 10 (Reuters) - India's Sun Pharmaceutical Industries (SUN.NS), opens new tab said on Monday it will acquire Checkpoint Therapeutics (CKPT.O), opens new tab, a U.S.-based immunotherapy and ...

I write about Asia's richest, fast-growing businesses, and startups. Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy ...